Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Myelogenous Leukemia, BCR/ABL Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02852486
What this trial is testing

Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response

Who this might be right for
Leukemia, Chronic Myeloid
University of Campinas, Brazil 31
Testing effectiveness (Phase 2)Study completedNCT01342679
What this trial is testing

Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib

Who this might be right for
Chronic Myeloid Leukemia
Kanto CML Study Group 21
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Ended earlyNCT00346632
What this trial is testing

An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+1 more
Kyowa Kirin, Inc. 37
Large-scale testing (Phase 3)Study completedNCT00406393
What this trial is testing

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

Who this might be right for
Leukemia, Myelocytic, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Myeloid, Chronic+1 more
Medical College of Wisconsin 304
Testing effectiveness (Phase 2)Study completedNCT01227356
What this trial is testing

A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia

Who this might be right for
Health Care QualityHealth Care Evaluation
Uppsala University 112
Testing effectiveness (Phase 2)Ended earlyNCT00539656
What this trial is testing

Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers

Who this might be right for
Acute Myeloid LeukemiaLeukemia, Lymphoblastic, AcuteLeukemia, Bilineage, Acute+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Not applicableEnded earlyNCT00062231
What this trial is testing

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more
European Organisation for Research and Treatment of Cancer - EORTC 351
Testing effectiveness (Phase 2)Study completedNCT01725204
What this trial is testing

Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
Norwegian University of Science and Technology 40
Early research (Phase 1)Study completedNCT01822509
What this trial is testing

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientMyeloproliferative NeoplasmRecurrent Acute Lymphoblastic Leukemia+8 more
National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)UnknownNCT03883087
What this trial is testing

A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
Ascentage Pharma Group Inc. 41
Testing effectiveness (Phase 2)WithdrawnNCT02973711
What this trial is testing

Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML

Who this might be right for
Leukemia, Chronic Myeloid
University of Michigan Rogel Cancer Center
Early research (Phase 1)Study completedNCT05640804
What this trial is testing

A Bioequivalence Study of Dasatinib Tablet

Who this might be right for
Leukemia, Myelogenous, Chronic
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 56
Testing effectiveness (Phase 2)UnknownNCT01887561
What this trial is testing

Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial

Who this might be right for
Myelogenous Leukemia, Chronic, Chronic Phase
Kanto CML Study Group 100
Testing effectiveness (Phase 2)Study completedNCT00042016
What this trial is testing

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Who this might be right for
Chronic Myelogenous Leukemia
Astex Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT01914484
What this trial is testing

Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia

Who this might be right for
Chronic Phase Chronic Myeloid LeukemiaAccelerated Phase Chronic Myeloid LeukemiaBlastic Phase Chronic Myeloid Leukemia+2 more
University Health Network, Toronto 4
Testing effectiveness (Phase 2)Study completedNCT00054327
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Case Comprehensive Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT03106779
What this trial is testing

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 233
Testing effectiveness (Phase 2)Ended earlyNCT00005986
What this trial is testing

Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota
Not applicableEnded earlyNCT00514722
What this trial is testing

Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+7 more
University of California, San Francisco 4
Next Page